Neera
☆    

India,
2023-05-15 11:24
(403 d 09:02 ago)

Posting: # 23552
Views: 1,245
 

 Gender Effect on Clarithromycin [Regulatives / Guidelines]

Hello Everyone,

Hope all good !!!

This is regarding one BE study on Clarithromycin Extended-Release Tablets, USP 500 mg conducted on healthy male subjects for USFDA regulatory.
Received query regarding explanation/scientific justification to support that the BE results from the male-only study can be extrapolated to the entire population consisting of both sexes and that the difference in study population will not affect the BE conclusion.

Searched literatures, but could not get any relevant data to conclude on above query. Your expert opinion is needed. How to handle this query?.

thanks to all.

Have a great day ahead.
UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,664 registered users;
35 visitors (0 registered, 35 guests [including 8 identified bots]).
Forum time: 20:27 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5